Mid-career students at Brown University’s new Executive Masters in Healthcare Leadership program are challenging the status quo with workplace projects focused on one thing: removing the organizational silos that slow innovations in the delivery and financing of healthcare.
Mid-career students at Brown University’s new Executive Masters in Healthcare Leadership program are challenging the status quo with workplace projects focused on one thing: removing the organizational silos that slow innovations in the delivery and financing of healthcare.
As the US healthcare system stumbles toward a new consensus built around the “triple aim” of increased access, improved quality, and lower cost, the push is on for new ideas that can test the boundaries of current practice. The Affordable Care Act (ACA) creates a range of incentives to promote this goal, which has added to the momentum around novel reform approaches. Business management schools have jumped with gusto into the fray, providing much of the intellectual heft for integrative, outcomes-oriented programs that stress patient wellness and require medicines to do more than just treat disease.
One institution, Brown University, has gone a step further than many of its counterparts, with a new 16-month Executive Master of Healthcare Leadership (EMHL) program dedicated to empowering mid-career health professionals with the diverse interests, skills and capabilities to challenge that status quo and “transform” healthcare as we now know it.
For more on this article, click on this month’s issue of Pharm Exec.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.